SOUTH KOREA · OPENDART
NGeneBio Co., Ltd.
엔젠바이오 · 354200 · KOSDAQ · Healthcare · Biotechnology
Score
44.0
Insider timeline
One insider bought, 2 times, the latest (27 Jul). The share closed at 2,205.00 that day and at 937.00 most recently (−57.5%).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
Blue line: this share's price, −82.0% over these six months
The closing price of each day, from 5,208.52 on 2026-04-21 to 937.00 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −31.9%
Taken from the 1525 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −82.0%, the typical one −31.9%, 50.1 points behind. It is not an index and not a comparison within one industry.
This company: insiders buying per month, last 12 months
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| KIM MINSIK | CEO / chair | 2 | — | 100.0M KRW | 2026-07-24 | −63.8% |
Insiders' buying price vs the latest close
Insiders paid 2,341.95 KRW a share on average (2 purchase lines, 1 buyer, 2026-07-24 – 2026-07-27). The close on 2026-10-16 was 60.0% below that price.
The latest purchase (2026-07-27) was at 2,380.00 KRW; the close was 60.6% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
Other changes in holdings · 30
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | S.H. Health care | 10% shareholder | Disposal in OTC(-) | 785,559 | DART ↗ |
| 2026-08-04 | S.H. Health care | 10% shareholder | Others(+) | 1,571,118 | DART ↗ |
| 2026-06-25 | S.H. Heaith care | 10% shareholder | Capital reduction | — | DART ↗ |
| 2026-06-25 | S.H. Heaith care | 10% shareholder | Capital reduction | 3,923,852 | DART ↗ |
| 2025-09-01 | Kim Kwang Joong | Executive | Disposal in OTC(-) | 108,000 | DART ↗ |
| 2025-09-01 | Hong Chang Bum | Division head | Disposal in OTC(-) | 6,000 | DART ↗ |
| 2025-08-01 | Hong Chang Bum | Division head | Disposal in OTC(-) | 94,000 | DART ↗ |
| 2025-08-01 | Choi Dae Chul | Vice chairman | Disposal in OTC(-) | 80,000 | DART ↗ |
| 2025-06-28 | S.H. Heaith care | 10% shareholder | New report(+) | 5,885,778 | DART ↗ |
| 2024-12-20 | Choi Dae Chul | CEO | 주식매수선택권(+) | 80,250 | DART ↗ |
| 2024-12-20 | Hong Chang Bum | Division head | 유상신주취득(+) | 31,673 | DART ↗ |
| 2024-12-18 | Choi Dae Chul | CEO | 유상신주취득(+) | 134,196 | DART ↗ |
| 2024-12-18 | Kim Kwang Joong | Inside director | 유상신주취득(+) | 43,240 | DART ↗ |
| 2024-12-18 | Yoon Se hyuk | Division head | 유상신주취득(+) | 14,977 | DART ↗ |
| 2024-12-18 | KIM JI Yeon | Division head | 유상신주취득(+) | 1,992 | DART ↗ |
| 2024-12-09 | Choi Dae Chul | CEO | 기타(-) | 110,701 | DART ↗ |
| 2024-12-09 | Kim Kwang Joong | Inside director | 기타(-) | 33,210 | DART ↗ |
| 2024-12-09 | Hong Chang Bum | Division head | 기타(-) | 25,830 | DART ↗ |
| 2024-12-09 | Yoon Se hyuk | Division head | 기타(-) | 11,070 | DART ↗ |
| 2024-12-09 | KIM JI Yeon | Division head | 기타(-) | 1,660 | DART ↗ |
| 2024-11-20 | Choi Dae Chul | CEO | 장외매도(-) | 129,500 | DART ↗ |
| 2024-11-20 | Kim Kwang Joong | Inside director | 장외매도(-) | 37,212 | DART ↗ |
| 2024-11-20 | Yoon Se hyuk | Division head | 장외매도(-) | 27,209 | DART ↗ |
| 2024-11-20 | Hong Chang Bum | Division head | 장외매도(-) | 77,958 | DART ↗ |
| 2024-11-20 | KIM JI Yeon | Division head | 장외매도(-) | 4,717 | DART ↗ |
| 2024-11-14 | Choi Dae Chul | CEO | 기타(+) | 240,201 | DART ↗ |
| 2024-11-14 | Kim Kwang Joong | Inside director | 기타(+) | 70,422 | DART ↗ |
| 2024-11-14 | Yoon Se hyuk | Division head | 기타(+) | 38,279 | DART ↗ |
| 2024-11-14 | Hong Chang Bum | Division head | 기타(+) | 103,788 | DART ↗ |
| 2024-11-14 | KIM JI Yeon | Division head | 기타(+) | 6,377 | DART ↗ |